Matt Galsky, MD, discusses the phase 3 NIAGARA trial that led to the recent FDA approval of durvalumab in muscle-invasive ...

Glyphosate is essentially inescapable in modern society, true. That said, exposure to glyphosate residue in foods at levels ...

This week, in response to President Trump's ongoing cuts to scientific research and staffing at federal agencies, nearly ...

The University of New Mexico Comprehensive Cancer Center has received a $2 million grant to study a form of immune therapy ...

Researchers developed a manufacturing technique that rapidly generates large quantities of nanoparticles coated with drug-delivering polymers, which hold great potential for treating cancer. The ...

The Trump administration's cuts to the National Institutes of Health has some worried about stalls in research and medicine.

April is Head and Neck Cancer Awareness Month, and it is important to be aware of early signs and symptoms of the disease, as well as when to seek care.

USC Norris Comprehensive Cancer Center, part of Keck Medicine of USC, has opened Keck Medicine of USC – Newport Beach ...

A phase 3 trial of nemvaleukin alfa in with Keytruda for patients with platinum-resistant ovarian cancer will not continue on ...

The University of Texas' busiest system by construction projects could be looking at more Houston expansions soon.

The technology, which in the past had been limited by size and cost, provides targeted doses of radiation to tumors, ...